Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Jason M Redman"'
Autor:
James L Gulley, Rong Deng, Carl Millward, Jason M Redman, Yao Chiang, Ariel Niedecken, Kacy Stadtmiller, Edward Garmey, Vincent Poon, Michael A Asensio, Janice Lansita, Kyle P Carter, Ellen K Wagner, Erica L Stone
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/cd7653e4b6fc47cc83ad4632ba2809b7
Autor:
Jeffrey Schlom, James L Gulley, Jennifer Marte, Elizabeth Lamping, Lisa Cordes, Seth M Steinberg, Charalampos Floudas, Jason M Redman, Clint Allen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/a3fab307059b40dc927bf48861453429
Autor:
Renee N Donahue, Jeffrey Schlom, James L Gulley, Ravi A Madan, Caroline Jochems, Elizabeth Lamping, Julius Strauss, Marijo Bilusic, Fatima Karzai, Christian S Hinrichs, Edward McClay, Jennifer L Marté, Lisa M Cordes, Andrew Hill, Byoung Chul Cho, Sébastien Salas, Laureen S Ojalvo, P Alexander Rolfe, Margaret E Gatti-Mays, Jason M Redman, Houssein A Sater, Andrea Burmeister, Genevieve Jehl
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Bintrafusp alfa is a first-in-class bifunctional fusion protein composed of the extracellular domain of transforming growth factor (TGF)-βRII (a TGF-β ‘trap’) fused to a human IgG1 mAb blocking programmed cell death ligand 1. This is
Externí odkaz:
https://doaj.org/article/8d0952dbd2c84693b0a6b1394990bc11
Autor:
Ravi A. Madan, Jason M. Redman, Fatima Karzai, William L. Dahut, Lisa Cordes, Farhad Fakhrejahani, Tuyen Vu, Nadeem Sheikh, Jeffrey Schlom, James L. Gulley
Publikováno v:
Journal of Immunotherapy. 46:145-151
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b0ddc25e40822a0fee440feb5e7ef57
https://doi.org/10.1097/cji.0000000000000459
https://doi.org/10.1097/cji.0000000000000459
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-8 (2018)
Abstract Advances in immunotherapy utilizing immune checkpoint inhibitors (ICIs) have transformed the treatment landscapes of several malignancies in recent years. Oncologists are now tasked with extending these benefits to a greater number of patien
Externí odkaz:
https://doaj.org/article/8eb18554c5924ffaac642ca544ec839d
Autor:
James L. Gulley, Jeffrey Schlom, Christopher R. Heery, Cesar Pico Navarro, Eva Wagner, Andrea Burmeister, Alanvin Orpia, Elizabeth Lamping, Lisa M. Cordes, Jennifer L. Marté, Ravi A. Madan, Jason M. Redman, Jaydira Del Rivero, Claudia Palena, Renee N. Donahue, Julius Strauss, Margaret E. Gatti-Mays
Purpose:BN-CV301 is a poxviral-based vaccine comprised of recombinant (rec.) modified vaccinia Ankara (MVA-BN-CV301; prime) and rec. fowlpox (FPV-CV301; boost). Like its predecessor PANVAC, BN-CV301 contains transgenes encoding tumor-associated antig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3f5b25865fb0afb72c49d7fca8cbf1
https://doi.org/10.1158/1078-0432.c.6528519
https://doi.org/10.1158/1078-0432.c.6528519
Autor:
James L. Gulley, Jeffrey Schlom, Christopher R. Heery, Cesar Pico Navarro, Eva Wagner, Andrea Burmeister, Alanvin Orpia, Elizabeth Lamping, Lisa M. Cordes, Jennifer L. Marté, Ravi A. Madan, Jason M. Redman, Jaydira Del Rivero, Claudia Palena, Renee N. Donahue, Julius Strauss, Margaret E. Gatti-Mays
Supplementary Table S1A: Phenotypic analysis of surface markers on human DCs transfected with MVA-BN-CV301 and FPV-CV301 vectors Supplementary Table S1B: Activation of CEA- and MUC1-specific T-cells by MVA-BN-CV301 and FPV-CV301 Supplementary Table S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a56f2d1ae1207bb367dea6c1ad6c8e4
https://doi.org/10.1158/1078-0432.22473483.v1
https://doi.org/10.1158/1078-0432.22473483.v1
Autor:
Jason M Redman, Yo-Ting Tsai, Benjamin A Weinberg, Renee N Donahue, Shruti Gandhy, Margaret E Gatti-Mays, Houssein Abdul Sater, Marijo Bilusic, Lisa M Cordes, Seth M Steinberg, Jennifer L Marte, Caroline Jochems, Sunnie S Kim, John L Marshall, Sheri McMahon, Erica Redmond, Jeffrey Schlom, James L Gulley, Julius Strauss
Publikováno v:
Oncologist
Background FOLFOX plus bevacizumab is a standard of care (SOC) for first-line treatment of microsatellite-stable metastatic colorectal cancer (MSS mCRC). This study randomized patients to SOC or SOC plus avelumab (anti-PD-L1) plus CEA-targeted vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b0799ac3ae4d2c2c8fac46a2130e79
https://doi.org/10.1093/oncolo/oyab046
https://doi.org/10.1093/oncolo/oyab046
Autor:
Jason M. Redman, Jay Friedman, Yvette Robbins, Cem Sievers, Xinping Yang, Wiem Lassoued, Andrew Sinkoe, Antonios Papanicolau-Sengos, Chyi-Chia Lee, Jennifer L. Marte, Evrim Turkbey, Wojtek Mydlarz, Arjun Joshi, Nyall R. London, Matthew Pierce, Rodney Taylor, Steven Hong, Andy Nguyen, Patrick Soon-Shiong, Jeffrey Schlom, James L. Gulley, Clint T. Allen
Publikováno v:
Journal of Clinical Investigation. 132
BACKGROUNDHead and neck squamous cell carcinoma not associated with HPV (HPV-unrelated HNSCC) is associated with a high rate of recurrence and poor survival.METHODSWe conducted a clinical trial in 14 patients with newly diagnosed HPV-unrelated HNSCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fae2720e9d62bee49482b8c698a29761
https://doi.org/10.1172/jci161400
https://doi.org/10.1172/jci161400
Autor:
Cem Sievers, Marco Craveiro, Jay Friedman, Yvette Robbins, Xinping Yang, Ke Bai, Andy Nguyen, Jason M. Redman, Raj Chari, Patrick Soon-Shiong, Jeffrey Schlom, James Gulley, Clint T. Allen
Publikováno v:
Cancer Cell. 41:887-902.e5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cb9fd8891ed79815412d1ae7b5be794
https://doi.org/10.1016/j.ccell.2023.03.014
https://doi.org/10.1016/j.ccell.2023.03.014